Celltrion USA Recalls Certain Point of Care DiaTrust COVID-19 Ag Rapid Test Kits Which May Have Been Distributed to Unauthorized, Non-CLIA-Certified Users

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Name: Celltrion DiaTrust COVID-19 Ag Rapid Test Product Codes: 83QKP Lot Numbers: See recall database entry Distribution Dates: December 2021 to February 2022 Devices Recalled in…

Potential Risk of Airway Obstruction When Using Certain Electromyogram Endotracheal Tubes – Letter to Health Care Providers

April 27, 2022 The U.S. Food and Drug Administration (FDA) is evaluating the potential risk of airway obstruction when using silicone-based electromyogram (EMG) endotracheal tubes (Medtronic NIM Standard Reinforced EMG Endotracheal Tube and Medtronic NIM Contact Reinforced EMG Endotracheal Tube). The FDA has received reports describing serious adverse events and deaths for these devices after…

Pfizer Voluntary Nationwide Recall of Lots of ACCUPRIL® (Quinapril HCl) Due to N-Nitroso-Quinapril Content

Summary Company Announcement Date: April 22, 2022 FDA Publish Date: April 22, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to N-Nitroso-Quinapril Content Company Name: Pfizer Brand Name: Brand Name(s) Product Description: Product Description Accupril (Quinapril HCl) tablets 10mg, 20mg, 40 mg Company Announcement FOR IMMEDIATE RELEASE – NEW YORK, NY., April…

Genetic Non-Invasive Prenatal Screening Tests May Have False Results: FDA Safety Communication

Discuss the results of genetic prenatal screening tests with a genetic counselor or other health care provider. Date Issued: April 19, 2022 The U.S. Food and Drug Administration (FDA) is warning patients and health care providers about the risks of false results with genetic non-invasive prenatal screening (NIPS) tests, sometimes called noninvasive prenatal testing or…

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch

Summary Company Announcement Date: April 12, 2022 FDA Publish Date: April 12, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Label may be missing on some vials Company Name: Mylan Pharmaceuticals, Inc. a Viatris Company Brand Name: Brand Name(s) Product Description: Product Description Insulin Glargine (Insulin glargine-yfgn) Injection Company Announcement FOR IMMEDIATE RELEASE…

Pfizer Voluntary Nationwide Recall of Lots of Accuretic (Quinapril HCl/Hydrochlorothiazide), Quinapril and Hydrochlorothiazide Tablets, and Quinapril HCl/Hydrochlorothiazide Tablets Due to N-Nitroso-Quinapril Content

Summary Company Announcement Date: March 22, 2022 FDA Publish Date: March 22, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Presence of a nitrosamine, N-nitroso-quinapril Company Name: Pfizer Brand Name: Brand Name(s) Accuretic, Greenstone Brand Product Description: Product Description Accuretic™ (quinapril HCl/hydrochlorothiazide); quinapril and hydrochlorothiazide; and quinapril HCl/hydrochlorothiazide tablets Company Announcement NEW YORK,…